Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials-Reference-Cited by-同舟云学术

Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials

Published:2023-08-19 Issue:11 Volume:53 Page:1019-1026
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Nakachi Kohei¹,Gotohda Naoto²,Hatano Etsuro³⁴,Nara Satoshi⁵^ORCID,Takahashi Shinichiro⁶,Kawamoto Yasuyuki⁷,Ueno Makoto⁸⁹

Affiliation:

1. Department of Medical Oncology, Tochigi Cancer Center , Utsunomiya , Japan

2. Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East , Kashiwa , Japan

3. Department of Surgery , Graduate School of Medicine, , Kyoto , Japan

4. Kyoto University , Graduate School of Medicine, , Kyoto , Japan

5. Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital , Tokyo , Japan

6. Department of Gastroenterological Surgery, Tokai University School of Medicine , Isehara , Japan

7. Division of Cancer Center, Hokkaido University Hospital , Sapporo , Japan

8. Department of Gastroenterology , Hepatobiliary and Pancreatic Medical Oncology Division, , Yokohama , Japan

9. Kanagawa Cancer Center , Hepatobiliary and Pancreatic Medical Oncology Division, , Yokohama , Japan

Abstract

Abstract The first randomized controlled trial of adjuvant chemotherapy for biliary tract cancer was reported in 2002. Since then, studies have continued, with efficacy reported for capecitabine in 2018 and S-1 in 2023. Oral fluoropyrimidines have become established as the standard of care. This article reviews the evidence from the randomized controlled trials reported to date and those that are ongoing or from which results have not yet been reported.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://academic.oup.com/jjco/article-pdf/53/11/1019/52871477/hyad103.pdf

Reference30 articles.

1. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition;Miyazaki;J Hepatobiliary Pancreat Sci,2015

2. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Banales;Nat Rev Gastroenterol Hepatol,2016

3. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the global burden of disease study 2017;Ouyang;Cancer,2021

4. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma;Takada;Cancer,2002